r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

LE

Luke Evnin

Insider · Director · HOWL

Luke Evnin files insider transactions with the SEC as a director of Werewolf Therapeutics (HOWL). We hold 45 disclosed purchases and sales filed since 4 January 2006, 3 of them in the last 90 days.

  • Files forHOWL
  • Disclosed buys and sells45 in all, 3 in the last 90 days
  • Last disclosure8 July 2026

Positions held

20 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 23 December 2020 — 7 July 2026Director · Werewolf Therapeutics (HOWL)115 Form 4 lines · source: SEC Form 4
  • Filed 6 October 2020 — 23 June 2022Director · Oncorus (ONCR)7 Form 4 lines · source: SEC Form 4
  • Filed 9 September 2021 — 2 December 202110% owner · iTeos Therapeutics (ITOS)25 Form 4 lines · source: SEC Form 4
  • Filed 20 October 2020 — 30 April 2021Chief Executive Officer · Turmeric Acquisition (TMPM)2 Form 4 lines · source: SEC Form 4
  • Filed 9 November 2018 — 15 April 2021Other role · Harpoon Therapeutics (HARP)36 Form 4 lines · source: SEC Form 4
  • Filed 23 June 2020 — 23 June 202010% owner · Repare Therapeutics (RPTX)5 Form 4 lines · source: SEC Form 4
  • Filed 19 February 2019 — 19 February 201910% owner · Tcr2 Therapeutics (TCRR)5 Form 4 lines · source: SEC Form 4
  • Filed 8 March 2016 — 23 May 2018Director and 10% owner · Syndax Pharmaceuticals (SNDX)11 Form 4 lines · source: SEC Form 4
  • Filed 23 April 2013 — 27 September 2016Other role · Radius Health (RDUS)12 Form 4 lines · source: SEC Form 4
  • Filed 20 October 2015 — 20 October 201510% owner · Cerecor (CERC)2 Form 4 lines · source: SEC Form 4
  • Filed 14 November 2007 — 7 May 2014Director · EnteroMedics (ETRM)28 Form 4 lines · source: SEC Form 4
  • Filed 8 February 2011 — 13 June 2013Director · Pacira Pharmaceuticals (PCRX)36 Form 4 lines · source: SEC Form 4
  • Filed 5 June 2013 — 5 June 201310% owner · Epizyme (EPZM)4 Form 4 lines · source: SEC Form 4
  • Filed 17 May 2011 — 14 December 201110% owner · Radius Health (NONE)6 Form 4 lines · source: SEC Form 4
  • Filed 11 October 2011 — 17 October 201110% owner · Zalicus (ZLCS)3 Form 4 lines · source: SEC Form 4
  • Filed 9 May 2006 — 27 January 2010Director and 10% owner · Metabasis Therapeutics (MBRX)11 Form 4 lines · source: SEC Form 4
  • Filed 1 May 2007 — 8 July 200910% owner · Somaxon Pharmaceuticals (SOMX)4 Form 4 lines · source: SEC Form 4
  • Filed 16 May 2006 — 16 July 2008Director and 10% owner · Restore Medical (REST)11 Form 4 lines · source: SEC Form 4
  • Filed 19 June 2008 — 23 June 2008Other role · Pharmasset (VRUS)14 Form 4 lines · source: SEC Form 4
  • Filed 12 September 2007 — 13 September 200710% owner · Hemosense (HEM)2 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.